RE:RE:RE:RE:RE:RE:RE:YEAR END FINANCIALS Here's Heritage's company profile below:
We are a vertically integrated Licensed Producer with two Health Canada approved facilities. Working under these licenses we formulate, extract, package, and deliver one of Canada’s most diverse and pure medical/recreational cannabis product assortments.
Our medical products are based on patented pharmaceutical drug delivery technology backed by independent third party data as well as product specific clinical and non-clinical studies to prove their utility for medical use having recently secured a partnership with Merida Capital, a prominent US private equity fund who target proven operating models and work to supercharge the growth of their commercial pipeline, Heritage now has access to an expansive international marketplace.
With revenue being driven in both Canada, the US, and other international markets we are poised to become a global leader in Cannabis.
CANN is domestically in every province and territory (except Nunavut) in Canada and internationally in three US states, Brazil and Australia and growing into more. So if you're not willing to take a chance at these levels than new investors will certainly miss the train.